Aforti Holding SA operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aforti Holding SA with three other
financial institutions in Europe:
BB Biotech AG
sales of 280.93 million Swiss Francs [US$312.84 million]
of which 100%
was Investing & Related Activity),
HBM Healthcare Investments AG
(235.06 million Swiss Francs [US$261.76 million]
Safmar Finansovye Investitsii PAO
based in RUSSIAN FEDERATION
(16.68 billion Russian Rubles [US$231.84 million]
Sales were up sharply during the first
quarter of 2021 versus the previous year's first quarter.
During the first
quarter of 2021, sales at Aforti Holding SA totalled
435.11 million Polish New Zlotys.
an increase of 205.9%
from the 142.25 million Polish New Zlotys in sales at the company during the first quarter of 2020.
Sales at Aforti Holding SA appear to have some seasonality: during each of the previous 5
years, sales have been highest during the fourth quarter, which has accounted for
between 35.1% and 43.9%
of the annual
During the year ended December of 2020, sales at
Aforti Holding SA were 1.01 billion Polish New Zlotys (US$271.83 million).
decrease of 2.5%
versus 2019, when the company's sales were 1.04 billion Polish New Zlotys.